Global Coronary Drug Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Coronary Drug Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Coronary Drug Market Overview:
Global Coronary Drug Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Coronary Drug involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Coronary Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Coronary Drug market in 2020.
Global Coronary Drug Market Segmentation
By Type, Coronary Drug market has been segmented into:
Durable Polymer Drug-eluting Stents
Bioabsorbable Polymer Drug-eluting Stent
Other
By Application, Coronary Drug market has been segmented into:
Coronary Heart Disease
Clinical
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Coronary Drug market are:
Boston Scientific
Cordis
Abbott
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Translumina
Vascular Concepts
JW Medical Systems
Kinhely
Lepu Medical
Medfavour Medical
1. Market Overview of Coronary Drug
1.1 Coronary Drug Market Overview
1.1.1 Coronary Drug Product Scope
1.1.2 Market Status and Outlook
1.2 Coronary Drug Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Coronary Drug Historic Market Size by Regions (2015-2020)
1.4 Coronary Drug Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Coronary Drug Sales Market by Type (2015-2026)
2.1 Global Coronary Drug Historic Market Size by Type (2015-2020)
2.2 Global Coronary Drug Forecasted Market Size by Type (2021-2026)
2.3 Durable Polymer Drug-eluting Stents
2.4 Bioabsorbable Polymer Drug-eluting Stent
2.5 Other
3. Covid-19 Impact Coronary Drug Sales Market by Application (2015-2026)
3.1 Global Coronary Drug Historic Market Size by Application (2015-2020)
3.2 Global Coronary Drug Forecasted Market Size by Application (2021-2026)
3.3 Coronary Heart Disease
3.4 Clinical
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Coronary Drug Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Coronary Drug Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Coronary Drug Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Coronary Drug Business
5.1 Boston Scientific
5.1.1 Boston Scientific Company Profile
5.1.2 Boston Scientific Coronary Drug Product Specification
5.1.3 Boston Scientific Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Cordis
5.2.1 Cordis Company Profile
5.2.2 Cordis Coronary Drug Product Specification
5.2.3 Cordis Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Abbott
5.3.1 Abbott Company Profile
5.3.2 Abbott Coronary Drug Product Specification
5.3.3 Abbott Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Advantec Vascular
5.4.1 Advantec Vascular Company Profile
5.4.2 Advantec Vascular Coronary Drug Product Specification
5.4.3 Advantec Vascular Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 B.Braun Melsengen AG
5.5.1 B.Braun Melsengen AG Company Profile
5.5.2 B.Braun Melsengen AG Coronary Drug Product Specification
5.5.3 B.Braun Melsengen AG Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Biosensors
5.6.1 Biosensors Company Profile
5.6.2 Biosensors Coronary Drug Product Specification
5.6.3 Biosensors Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Biotronik
5.7.1 Biotronik Company Profile
5.7.2 Biotronik Coronary Drug Product Specification
5.7.3 Biotronik Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Blue Medical
5.8.1 Blue Medical Company Profile
5.8.2 Blue Medical Coronary Drug Product Specification
5.8.3 Blue Medical Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 DISA Vascular
5.9.1 DISA Vascular Company Profile
5.9.2 DISA Vascular Coronary Drug Product Specification
5.9.3 DISA Vascular Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Essen
5.10.1 Essen Company Profile
5.10.2 Essen Coronary Drug Product Specification
5.10.3 Essen Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Medtronic Vascular
5.11.1 Medtronic Vascular Company Profile
5.11.2 Medtronic Vascular Coronary Drug Product Specification
5.11.3 Medtronic Vascular Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 MicroPort Medical
5.12.1 MicroPort Medical Company Profile
5.12.2 MicroPort Medical Coronary Drug Product Specification
5.12.3 MicroPort Medical Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 MIV Therapeutics
5.13.1 MIV Therapeutics Company Profile
5.13.2 MIV Therapeutics Coronary Drug Product Specification
5.13.3 MIV Therapeutics Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Orbusneich
5.14.1 Orbusneich Company Profile
5.14.2 Orbusneich Coronary Drug Product Specification
5.14.3 Orbusneich Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Promed Medical
5.15.1 Promed Medical Company Profile
5.15.2 Promed Medical Coronary Drug Product Specification
5.15.3 Promed Medical Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Relisys Medical
5.16.1 Relisys Medical Company Profile
5.16.2 Relisys Medical Coronary Drug Product Specification
5.16.3 Relisys Medical Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 Reva Medical
5.17.1 Reva Medical Company Profile
5.17.2 Reva Medical Coronary Drug Product Specification
5.17.3 Reva Medical Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 Sahajanand
5.18.1 Sahajanand Company Profile
5.18.2 Sahajanand Coronary Drug Product Specification
5.18.3 Sahajanand Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 Sino Medical
5.19.1 Sino Medical Company Profile
5.19.2 Sino Medical Coronary Drug Product Specification
5.19.3 Sino Medical Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.20 Sorin
5.20.1 Sorin Company Profile
5.20.2 Sorin Coronary Drug Product Specification
5.20.3 Sorin Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.21 Terumo Medical
5.21.1 Terumo Medical Company Profile
5.21.2 Terumo Medical Coronary Drug Product Specification
5.21.3 Terumo Medical Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.22 Translumina
5.22.1 Translumina Company Profile
5.22.2 Translumina Coronary Drug Product Specification
5.22.3 Translumina Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.23 Vascular Concepts
5.23.1 Vascular Concepts Company Profile
5.23.2 Vascular Concepts Coronary Drug Product Specification
5.23.3 Vascular Concepts Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.24 JW Medical Systems
5.24.1 JW Medical Systems Company Profile
5.24.2 JW Medical Systems Coronary Drug Product Specification
5.24.3 JW Medical Systems Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.25 Kinhely
5.25.1 Kinhely Company Profile
5.25.2 Kinhely Coronary Drug Product Specification
5.25.3 Kinhely Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.26 Lepu Medical
5.26.1 Lepu Medical Company Profile
5.26.2 Lepu Medical Coronary Drug Product Specification
5.26.3 Lepu Medical Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.27 Medfavour Medical
5.27.1 Medfavour Medical Company Profile
5.27.2 Medfavour Medical Coronary Drug Product Specification
5.27.3 Medfavour Medical Coronary Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Coronary Drug Market Size (2015-2026)
6.2 North America Coronary Drug Key Players in North America (2015-2020)
6.3 North America Coronary Drug Market Size by Type (2015-2020)
6.4 North America Coronary Drug Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Coronary Drug Market Size (2015-2026)
7.2 East Asia Coronary Drug Key Players in North America (2015-2020)
7.3 East Asia Coronary Drug Market Size by Type (2015-2020)
7.4 East Asia Coronary Drug Market Size by Application (2015-2020)
8. Europe
8.1 Europe Coronary Drug Market Size (2015-2026)
8.2 Europe Coronary Drug Key Players in North America (2015-2020)
8.3 Europe Coronary Drug Market Size by Type (2015-2020)
8.4 Europe Coronary Drug Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Coronary Drug Market Size (2015-2026)
9.2 South Asia Coronary Drug Key Players in North America (2015-2020)
9.3 South Asia Coronary Drug Market Size by Type (2015-2020)
9.4 South Asia Coronary Drug Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Coronary Drug Market Size (2015-2026)
10.2 Southeast Asia Coronary Drug Key Players in North America (2015-2020)
10.3 Southeast Asia Coronary Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Coronary Drug Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Coronary Drug Market Size (2015-2026)
11.2 Middle East Coronary Drug Key Players in North America (2015-2020)
11.3 Middle East Coronary Drug Market Size by Type (2015-2020)
11.4 Middle East Coronary Drug Market Size by Application (2015-2020)
12. Africa
12.1 Africa Coronary Drug Market Size (2015-2026)
12.2 Africa Coronary Drug Key Players in North America (2015-2020)
12.3 Africa Coronary Drug Market Size by Type (2015-2020)
12.4 Africa Coronary Drug Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Coronary Drug Market Size (2015-2026)
13.2 Oceania Coronary Drug Key Players in North America (2015-2020)
13.3 Oceania Coronary Drug Market Size by Type (2015-2020)
13.4 Oceania Coronary Drug Market Size by Application (2015-2020)
14. South America
14.1 South America Coronary Drug Market Size (2015-2026)
14.2 South America Coronary Drug Key Players in North America (2015-2020)
14.3 South America Coronary Drug Market Size by Type (2015-2020)
14.4 South America Coronary Drug Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Coronary Drug Market Size (2015-2026)
15.2 Rest of the World Coronary Drug Key Players in North America (2015-2020)
15.3 Rest of the World Coronary Drug Market Size by Type (2015-2020)
15.4 Rest of the World Coronary Drug Market Size by Application (2015-2020)
16 Coronary Drug Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Coronary Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|